The allogeneic mixed lymphocyte reaction (MLR) is a complex in vitro assay of T-cell recognition and responsiveness in which interleukin-2 (IL-2) plays a central role. We have previously demonstrated that e-kit ligand (KL) can enhance IL-2-induced proliferation in a subset of human natural killer cells expressing the c-kit tyrosine kinase receptor. In the present study, we asked whether KL could enhance IL-2-mediated T-cell proliferation in the allogeneic MLR. We demonstrate that the vast majority of activated human T-cell clones express the c-kit mRNA transcript. Binding studies performed on activated T cells with radioiodinated KL were consistent with the expression of a single class of c-kit receptors. The addition of exogenous KL to the MLR led to an HE ALLOGENEIC primary mixed lymphocyte re-
T sponse (MLR) is a complex in vitro assay of T-lymphocyte recognition and responsiveness to determinants expressed on genetically nonidentical antigen-presenting cells. Reactivity during the MLR, as usually measured by tritiated thymidine (3[H]-TdR) incorporation, reflects the T-cell proliferative response to differences in donor and recipient major histocompatibility complex (MHC) antigen expression. Indeed, genetically different individuals who are completely matched at class I and class I1 MHC determinants have a nonreactive MLR. A reactive MLR can predict adverse immunologic sequelae in the setting of clinical organ transplantation, such as allograft rejection or graft versus host disease.' While the cytokine receptors and ligands that are involved in an MLR are numerous and incompletely characterized, the T-cell lymphocytotrophic hormone interleukin (1L)-2 has been shown to have a central role in promoting T-cell reactivity in Stem cell factor (SCF) or kit ligand (KL) is the ligand for the c-kit tyrosine kinase receptor protein, and is relatively abundant as a soluble factor in human Alone, KL has only minimal proliferative or differentiative effects on cells expressing c-kit, yet it acts in synergy with a number of growth factors including IL-3, IL-6, erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in promoting both cell growth and cell differentiation.'.'' Recently, we demonstrated that KL potentiates IL-2-induced proliferation in a subset of natural killer (NK) cells constitutively expressing both c-kit and the heterotrimeric high-affinity IL-2 receptor (IL-2R)." Kees and Ashman" demonstrated similar synergy in a T-cell acute lymphoblastic leukemia cell line. Puddington et all3 have demonstrated that murine intestinal intraepithelial T cells express transcript for c-kit and depend on interactions between KL and c-kit for normal homeostasis in the intestine. Likewise, KL significantly enhances T lymphopoiesis when human CD34+ adult bone marrow cells are cultured on thymic stroma in vitro. In the present study, we investigated whether activated human peripheral blood T cells express the c-kit gene product and assessed these cells for their functional responsiveness to KL during the MLR. 
MATERIALS AND METHODS
Nonreactive mouse immunoglobulin (MsIg) was purchased from Sigma Immunochemicals (St Louis, MO). Leu 4 (anti-CD3)-FITC, Leu 3A (anti-CD4)-PE and -FITC, Leu 2A (anti-CD8)-FITC and MsIg-PE were purchased from Becton Dickinson (San Jose, CA). The anti-c-kit MoAb (SR-1) was kindly provided as sterile ascites by Dr Virginia C. Broudy (University of Washington, Seattle, WA). Anti-Tac (anti-CD25) MoAb was kindly provided as sterile ascites by Dr Kendall Smith (Come11 University Medical College, New York, NY), and 2T8-5H7 was used as a nonreactive isotype control. Anti-CD2, anti-CD2R, anti-CD5 and anti-CD56 MoAbs were kindly provided as sterile mouse ascites by Dr Stuart Schlossman (Dana Farber Cancer Institute, Boston, MA). Anti-CD16 MoAb was kindly provided by Dr Jay Unkless (Mt. Sinai Hospital, New York, NY). Anti-HLA DR MoAb 3F5B11 has been described."
Human peripheral blood was obtained from buffy coats collected at the American Red Cross (Buffalo, NY). Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll-hypaque (Sigma) density centrifugation. The cells were washed twice and resuspended in RPMI 1640 containing 10% human AB serum (C-six Diagnostics, Inc, Mequon, WI), and antibiotics (GIBCO, Grand Island, NY) referred to hereafter as "medium".
MLR. Recombinant human IL-2 (specific activity: 2.7 X lo4 U/mg; Hoffman-La Roche Inc, Nutley, NJ) was diluted and used in an identical fashion where noted. For immunofluorescent cell sorting experiments, PBMC were incubated in an allogeneic MLR for 72 hours, removed from culture, and incubated at 4°C with an excess (10 pg) of unlabeled mouse Ig for 10 minutes, followed by the addition of anti-CD4-FITC and anti-CD8-PE. After an additional 30 minutes of incubation at 4"C, cells were washed once and sorted for CD4' and CD8' populations on a FACStdLUS (Becton Dickinson Systems, San Jose, CA). Reanalysis of sorted populations demonstrated purity of ~9 8 % .
Sorted populations of CD4+ and CD8' T cells were next plated into 96-well round bottom plates under one of four culture conditions: (1) medium only; (2) 50 pmolL (12 UlmL 750 pg/mL) IL-2; (3) 
Histocompatibility testing.
Cytokines.
Proliferation assay for sorted CD4' and CD8' T cells.
T-cell cloning and RNA isolation. Fresh PBMCs were adhered to plastic at 37°C for 1 hour, after which nonadherent PBMCs were treated with MoAbs reactive against CD16, CD56, and HLA-DR and depleted with immunomagnetic beads as described above. Single cell T-lymphocyte clones were generated from the remaining population by limiting dilution into 96-well plates at a frequency of 0.8 cellslwell. All wells included 2 x 10' allogeneic PBMCs that had been irradiated with 4,000 rads as feeder cells. At the time of plating each well received IL-2 at a final concentration of 1 nmolL along with T l l z and T113 MoAbs (1:200) as de~cribed.'~ After 3 weeks in culture, clones were harvested and verified for T-cell phenotype by flow cytometry. Total cellular RNA was isolated from all cells by adding RNAzol (Biotecx Laboratories, Friendswood, TX) directly to the well following aspiration of culture media and following the manufacturer's recommendation. An equal number of wells were cultured with irradiated feeder cells alone and also processed for RNA as above.
Reverse transcription-polymerase chain reaction (RT-PCR). First strand cDNA synthesis and subsequent PCR amplification were performed using an rTth enzyme kit (Perkin-Elmer, Norwalk, CT) following the manufacturer's instructions. Primers specific for the amplification of the human c-kit transcript by RT-PCR were obtained from Clontech (Palo Alto, CA) and used according to the manufacturer's recommendations. A total of 2 pL of the initial PCR product were then included in a hemi-nested PCR to obtain the final 531-bp product. Amplification of the hemi-nested sequence was performed using the upstream Clontech primer and a nested downstream primer (5'-CATCCGGAAGCCTTCCrrGA-3'). The 50-pL total reaction volume used for this step contained: 10 mmol/L Tris HC1, 50 mmol/L KC1, 1.5 mmoVL MgCl, , 50 mmol/L dNTPs, 10 pmoV L primers, 2 U Amplitaq (Perkin-Elmer, Foster City, CA), and 40.6 mL molecular grade H20 (Sigma). Thermal cycling of this step was performed using identical conditions as those used in the first round of PCR amplification. RNA obtained from the c-kit' M-07e cell line was used as a positive control along with human c-kit cDNA (Clontech, Palo Alto, CA). Epstein-Barr Virus latent membrane protein (EBV LMP) transcript (generously provided by Dr R.A. Baiocchi, Roswell Park Cancer Institute, Buffalo, NY) and water were used as negative controls. The integrity of RNA samples was verified by RT-PCR amplification using primers specific for human 0-actin (Clontech, Palo Alto, CA). The amplified PCR products were electrophoresed in 1.0% agarose gels, stained with ethidium bromide and visualized with UV transillumination.
PBMC were obtained from human leukopacs and depleted of non-T cells using magnetic beads as described above. Purity of the T-cell specimen was determined as >90% by FACS analysis. The specimen was divided into two groups, one of which was immediately lysed for RNA extraction and the other was activated for 72 hours in culture with phytohemaglutinin (PHA; Sigma), followed by RNA extraction. RNase protection assay for quantitation of c-kit mRNA was then performed as previously described."
T cells (>90% CD3+) were isolated from fresh leukopacs using immunomagnetic bead depletion and incubated for 48 hours in medium plus PHA (Sigma) at 3 pg/mL. Binding analyses were then performed using a modification of a previously described method." Briefly, the cells were washed twice with PBS (pH 7.4) and resuspended at 2.0 x lo6 cellslmL in binding buffer consisting of medium prewarmed to 37°C. The cells were incubated for 1 hour at 37°C with varying concentrations of Iz5I-KL, ranging from 0.01 to 3 nmolL, in the presence or absence of a 1.000-fold excess of unlabeled KL in a final volume of 200 pL. After incubation, the tubes were vortexed, and the cells were pelleted by centrifugation. Following snap freezing in liquid nitrogen, the cells pellets were separated from the RNase protection assay for c-kit mRNA.
'"I-KL binding and unlabeled ligand competition.
For supernatants and the radioactivity contained in both fractions was measured in a gamma counter. All binding experiments were performed in duplicate. Specific binding was defined as the amount of binding competed by a 1 .Oo-fold excess of unlabeled KL. Binding data were analyzed according to the method of Scatchard"' and by weighted nonlinear least-squares curve fitting as described by Munson and Rodbard" using the LIGAND program. Objective statistical criteria (F test, extra sum squares principle) were used to evaluate the goodness of fit and for discriminating between receptor binding models.
RESULTS
Detection of e-kit in activated T l~mphocytrs. To determine whether activated T cells express the c-kit gene product, we performed RT-PCR for the e-kit mRNA transcript on 23 T-cell clones. The results are shown in Fig IA and B. Of the 23 T-cell clones tested, 22 (95.6%) had expression of c-kit transcript. The clone that did not express c-kit mRNA (Fig 1 A, lane 6 cules present per cell. Resting T cells expressed 0.6 copies/ cell, while activated T cells from the same individual expressed 2.6 copieskell (data not shown).
We were unable to detect surface expression of c-kit protein by flow cytometric analysis when gating on CD4' or CD8 '-T-cell subsets following PHA activation (data not shown). However, receptor binding studies with radiolabeled KL were performed on enriched (>90%) populations of PHA-activated T cells. In three separate experiments, a single class of receptors for c-kit was detected with a KCi of 1.3 to 9.4 nmol/L and an expression density of 126 to 571 sites per cell (Fig IC) .
In an earlier report, we demonstrated that KL enhances IL-2-induced proliferation of human NK cells constitutively expressing c-kit and the highaffinity IL-2R." We hypothesized that KL may also augment
Egect of KL on the MLR.
IL-%-induced proliferation following T-cell activation. The classical one-way allogeneic MLR was used to reproduce near physiologic activation of T cells. As can be seen from Fig 2A, there was minimal reactivity between two HLAmatched individuals, yet the addition of KL resulted in a doubling of the proliferative response. In the one-way primary allogeneic MLR performed with PBMC from HLA-mismatched individuals, there was substantial reactivity in the absence of exogenous cytokines, and the addition of exogenous KL significantly augmented proliferation (-140%) over that seen in medium alone (Fig 2B) . The effect of KL in augmenting the proliferative response during the MLR between HLA-mismatched PBMC was dose-dependent (Fig 2C) . The addition of KL at concentrations as low as 0.08 nmol/L, which approximates its physiologic range in vivo,x resulted in a reproducible increase in proliferFor personal use only. on October 22, 2017 . by guest www.bloodjournal.org From ation above that seen in the absence of exogenous cytokines. At a concentration of 8.0 nmol/L (250 ng/mL), the proliferative response within the primary allogeneic MLR increased as much as 300% over that observed in medium alone ( Fig  2C) . The effect of exogenously added KL on the MLR could be completely inhibited in the presence of an anti-c-kit MoAb that blocks KL binding (Fig 2D) .
The increase in 3[H]-TdR uptake following a MLR is thought to result from the T-cell proliferative response following alloactivation.' To determine if exogenous KL was enhancing Tcell proliferation during the allogeneic MLR, two sets of experiments were performed. First, T cells were depleted from the responder PBMC using a combination of MoAbs and immunomagnetic beads. The remaining PBMC were plated against non-T-cell-depleted irradiated stimulator PBMC in one-way primary MLR at a 1: 1 ratio. The depletion of 297% of responder T cells resulted in a profound (>90%) reduction in the proliferative response following 96 hours in the MLR (Fig 3) . Importantly, the potentiating effect of KL on the MLR following T-cell depletion was reduced by >90% compared with the non-T-cell-depleted proliferative response seen in the presence of KL.
In the second set of experiments, CD4+ and CD8+ Tcell subsets were sorted to 297% purity by flow cytometry following 3 days of culture in a one-way primary allogeneic MLR, and then plated in the presence of medium alone, KL, IL-2, or KL plus IL-2. The results show that KL alone did not increase proliferative activity over medium alone. In contrast, the addition of IL-2 resulted in a sevenfold increase in the proliferative response. When KL was added to medium containing IL-2, the proliferative response was enhanced by approximately 30% over IL-2 alone for both T-cell subsets (Fig 4A and 4B) . Collectively, these two experiments suggest that KL can directly enhance proliferating T cells in an allogeneic MLR. 
KL potentiates IL-2-induced proliferation. Endogenous production of IL-2 by alloreactive T cells is pivotal to the T-cell proliferative response in
To determine if KL was potentiating L-2-induced proliferation, the allogeneic MLR was performed in the presence or absence of anti-Tac MoAb, which blocks the binding of IL-2 to the high-affinity IL-2R." As can be seen in Fig 5, the presence of anti-Tac MoAb diminishes 3[H]-TdR incorporation in the primary allogeneic MLR. While the presence of KL significantly enhances the proliferative response during the MLR in the presence of a control MoAb, enhancement by KL is completely abrogated in the presence of the anti-Tac MoAb. The effect of KL on the MLR, therefore, appears to require IL-2 binding to the high-affinity L 2 R .
DISCUSSION
In the present study, we demonstrate that the vast majority of activated T-cell clones express the c-kit gene product, and we provide evidence of KL-specific binding in polyclonal populations of activated T cells. We show that KL, the ligand for the c-kit tyrosine kinase receptor, can enhance the T-cell proliferative response during a one-way allogeneic MLR. We demonstrate that an anti-c-kit MoAb, which prevents KL binding to c-kit, completely blocks the ability of KL to enhance the proliferative response during the MLR. We also show that KL enhances IL-2-induced proliferation in highly purified T cells isolated from an MLR. Collectively, these data suggest that T cells can express a functional c-kit receptor during the MLR which, when activated, can enhance Tcell proliferation.
The failure to detect surface density expression of the c-kit protein on activated T cells by flow cytometry may be due to the low level of receptor expression as determined by receptor binding assays, which is also consistent with the RT-PCR and RNase protection assays showing few copies of c-kit transcripts per cell. The number of receptor sites per cell, therefore, appears sufficient for a biologic effect, yet are insufficient for detection by flow cytometry. The CD56h"Fh' NK cell population expresses a functional heterotrimeric high-affinity IL-2Rcrpy, yet surface expression of either IL-2Ra (CD25)'' or IL-2RyZ4 are lacking by flow cytometry. Likewise, intraepithelial yS T cells that reside within the intestinal epithelium lack surface expression of the c-kit protein by flow cytometry yet possess c-kit mRNA transcript by RT-PCR and are dependent on KL for normal homeostasis."
Studies in the IL-2-deficient mouse have shown that IL-2 is a critical component during the MLR, which is consistent with the upregulation of the high-affinity IL-2R following T-cell activation.'.' Two observations made in the current study suggest that KL enhances the T-cell proliferative response during the MLR by potentiating the signaling that occurs via the IL-2R. First, when highly purified T cells were separated from a 3-day MLR and placed again in culture, KL was only able to enhance their proliferation in the presence of exogenous IL-2. Second, in the presence of anti-Tac, which prevents the endogenous IL-2 from binding to its high-affinity IL-2R," the potentiating effect of KL during the MLR was completely lost, suggesting that costimulation via the IL-2R was a necessary component for its effect.
The mechanism by which activation of the c-kit tyrosine kinase receptor may enhance the proliferative signal produced by the activated IL-2R is unknown. The IL-2Rpy are the signal transducing subunits and members of the cytokinereceptor superfamily. Other members of the family can also synergize with KL following activation, including the IL-3 receptor, G-CSF receptor and the EPO This family of receptors lacks kinase-or phosphatase-related sequences in their cytosolic domains, instead relying in part on the janus kinase (JAK) family for receptor tyrosine-phosphorylation and ultimately, mitogenesis." Somewhat surprisingly, synergy between EPO and KL results when an activated c-kit induces tyrosine phosphorylation of the EPO receptor, and when c-kit, with intrinsic tyrosine kinase activity, physically associates with a portion of the EPO receptor not used by JAK2.*6 Whether a similar mechanism is applicable to c-kit and other members of the cytokine-receptor superfamily such as the IL-2R, or whether synergy lies further downstream with intracellular or nuclear signaling intennediates is currently unknown. Another possibility is that KL upregulates the high-affinity IL-2R on lymphocytes, but we have not seen evidence for this on T cells or NK cells.'' Increased IL-2 production also seems unlikely, as activated T cells removed from the MLR do not proliferate in the presence of KL alone. It is possible that KL synergizes with other lymphokines such as IL-1, IL-4, interferon-y, or tumor necrosis factor, all of which are thought to have a stimulatory role in the allogeneic MLR.".*' However, the complete loss of KL's effect in the presence of anti-Tac MoAb suggests that this is not likely to represent a dominant mechanism of action.
The effect of KL on the MHC-mismatched MLR proliferative response appears to be dose-dependent, with a small but significant contribution attributable to concentrations of KL that approximate those found in normal human serum.' This implies that endogenous KL could have a regulatory role in vivo during T-cell alloreactivity, viral infection, or autoimmune disorders, as could endogenous production of soluble c-kit receptors.*' Higher serum concentrations produced by exogenous administration of KL might further enhance Tcell responsiveness. Further elucidation of the interactions between KL and c-kit receptor expression on human lymphocytes will hopefully lend additional insight into the role(s) of this cytokine during the normal immune response. For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From
